Cimicoxib

Cimicoxib is a non-steroidal anti-inflammatory substance (NSAID) used for its anti-inflammatory, analgesic, and antipyretic properties. Cimicoxib is used to manage pain and inflammation in dogs, particularly for conditions such as osteoarthritis and acute injuries. Read more

Cimicoxib is a non-steroidal anti-inflammatory substance (NSAID) used for its anti-inflammatory, analgesic, and antipyretic properties. Cimicoxib is used to manage pain and inflammation in dogs, particularly for conditions such as osteoarthritis and acute injuries.

Essential insights

• COX-2 Inhibition: Cimicoxib primarily inhibits cyclooxygenase-2 (COX-2), an enzyme responsible for the production of prostaglandins that mediate inflammation, pain, and fever. By blocking COX-2, cimicoxib reduces the synthesis of these inflammatory mediators, leading to decreased inflammation, pain, and fever.
• Selective Action: Unlike some NSAIDs that inhibit both COX-1 and COX-2, cimicoxib is selective for COX-2. COX-1 is involved in maintaining normal physiological functions such as gastric mucosa protection and platelet aggregation. By selectively inhibiting COX-2, cimicoxib aims to minimize gastrointestinal and renal side effects associated with non-selective NSAIDs.
• Anti-inflammatory and Analgesic Effects: The reduction in prostaglandin production decreases inflammation and pain, providing symptomatic relief for conditions like osteoarthritis, postoperative pain, and other inflammatory disorders.